SCHEMBL1982206

SCHEMBL1982206

COc1ccc2[nH]c3cnc(-c4cccnc4)cc3c2c1-c1ccc(CNS(C)(=O)=O)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NEK1 Q96PY6 4/20 0.42
AURKA O14965 1/20 0.41
AURKB Q96GD4 1/20 0.41
CNR1 P21554 1/20 0.41
PIM1 P11309 3/20 0.41
PIM3 Q86V86 1/20 0.41
PIM2 Q9P1W9 1/20 0.41
CHEK1 O14757 1/20 0.41
ACHE P22303 1/20 0.41
WNT1 P04628 2/20 0.40
TGFBR1 P36897 2/20 0.40
SMN1; SMN2 Q16637 1/20 0.39
PKM P14618 1/20 0.39
TLR8 Q9NR97 2/20 0.39
TLR7 Q9NYK1 2/20 0.39
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2D6 P10635 1/20 0.38
TSHR P16473 1/20 0.38
CYP2C19 P33261 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1980283 0.92 AURKA (0.48) AURKAAURKBPIM1PIM3PIM2
SCHEMBL12597231 0.90 NEK1 (0.52) NEK1PIM1PIM3PIM2CHEK1
SCHEMBL1980607 0.88 IDO1 (0.47) PIM1PIM3PIM2TLR8TLR7
SCHEMBL1984328 0.87 MTNR1A (0.45) NEK1AURKAAURKBPIM1PIM3
SCHEMBL1980257 0.85 PIM1 (0.52) PIM1PIM3PIM2TLR8TLR7
SCHEMBL12597622 0.85 TLR7 (0.43) PIM1WNT1TLR8TLR7CYP1A2
SCHEMBL12597839 0.83 FYN (0.44) PIM1PIM3PIM2TGFBR1CYP1A2
SCHEMBL12597446 0.83 FFAR1 (0.44) NEK1PIM1PIM3PIM2CHEK1
SCHEMBL1561203 0.82 CHEK1 (0.45) AURKAAURKBCNR1PIM1PIM3
SCHEMBL12597452 0.82 PIM1 (0.49) PIM1PIM3PIM2TLR8TLR7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011070299-A1 TRI-SUBSTITUTED 9H-BETA-CARBOLINE (OR 9H-PYRIDO[3,4-B]INDOLE) DERIVATIVES, PREPARATION OF SAME AND THERAPEUTIC USE THEREOF SANOFI-AVENTIS (FR) 2011-06-16 WO disclosed